Skip to content

Ultrasound-guided acupuncture of the sphenopalatine ganglion in the treatment of acute ischemic stroke Trial-1

Evaluating the Efficacy of Ultrasound-Guided Acupuncture of the Sphenopalatine Ganglion in Improving Limb Function for Ischemic Stroke within 24 Hours after Onset.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000356
Enrollment
Unknown
Registered
2024-09-02
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

control:acupuncture -Jin San Zhen
SPG:SPG AND acupuncture-Jin San Zhen

Sponsors

The First People's Hospital of Guangzhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Patients with symptoms and signs of an acute ischemic stroke . 2.Within 24h of onset 3.NIHSS =1 and =16. 4.Age:=18 and =85 years of both genders. 5.Signed informed consent has been obtained from the patient him/herself or his/her legally authorized representative.

Exclusion criteria

Exclusion criteria: Patients who have received thrombolytic or endovascular treatment (including arterial thrombolysis bridging mechanical thrombectomy angioplasty and stenting). Patients with stroke confirmed to be caused by brain tumors brain trauma blood disorders etc. through examinations. Patients with a history of stroke and severe sequelae that significantly affect the outcome assessment that is with a modified Rankin Scale score = 2 before the current stroke onset. Other implanted neural stimulators or electronic devices. Patients with a history of oral and facial surgeries that affect acupuncture. Patients with other diseases affecting limb motor function. Those with limb motor dysfunction caused by claudication osteoarthritis rheumatoid arthritis gouty arthritis etc. before treatment that affects the neurological function examination. Patients with severe liver or kidney dysfunction. People with allergic constitutions or allergies to the research needles. People suffering from other serious diseases with an expected survival time of less than 3 months. Patients with large-area infarction (NIHSS score > 16 points) or dementia or with other mental impairments that the researcher deems unsuitable for participating in the study. Pregnant or lactating women. People who have participated in other clinical trials in the recent 3 months.

Design outcomes

Primary

MeasureTime frame
Grip strength;NIHSS;

Secondary

MeasureTime frame
FMA;mRS;

Countries

China

Contacts

Public ContactTing Xu

Guangzhou First People's Hospital

eyxuting@scut.edu.cn15521121137

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026